ICD-10 Coding for Basal Cell Carcinoma of the Nose(C44.3, C44.311, C44.311B)
Learn about ICD-10 coding for basal cell carcinoma of the nose, including specific codes, documentation requirements, and common pitfalls.
Complete code families applicable to Basal Cell Carcinoma of the Nose
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C44.311 | Basal cell carcinoma of skin of nose | Use when BCC is specifically documented on the nose. |
|
| C44.319 | Basal cell carcinoma of skin of other parts of face | Use when BCC is documented on the face but not specifically on the nose. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBasal Cell Carcinoma of the Nose
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Basal Cell Carcinoma of the Nose.
Omitting lesion size in documentation
Impact
Clinical: Impacts treatment planning and follow-up., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to insufficient detail.
Mitigation
Always measure and document lesion size., Include size in all clinical notes.
Using unspecified codes for documented nasal lesions
Impact
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Use C44.311 when the lesion is on the nose.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used for documented nasal lesions.
Mitigation
Ensure documentation specifies nasal subunit to support specific coding.